News

Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
Regulatory News - June 2021Regulatory News - June 2021Press release: Cell and Gene Therapy Catapult brings together over 20 organisations with the aim to accelerate technology development and potentially lower cost in cell and gene therapy manufacturingPress release: Cell and Gene Therapy Catapult brings together over 20 organisations with the aim to accelerate technology development and potentially lower cost in cell and gene therapy manufacturingRegulatory News - May 2021Regulatory News - May 2021Regulatory News - April 2021Regulatory News - April 2021Regulatory news - March 2021Regulatory news - March 2021Regulatory news - February 2021Regulatory news - February 2021Regulatory News - January 2021Regulatory News - January 2021Regulatory News - December 2020Regulatory News - December 2020Regulatory News - November 2020Regulatory News - November 2020Press release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPress release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPost-Brexit transition guidance for the cell and gene therapy industryPost-Brexit transition guidance for the cell and gene therapy industryRegulatory News - October 2020Regulatory News - October 2020